From: The utility of surgical lung biopsy in cancer patients with acute respiratory distress syndrome
Age, mean±SD | 55 ± 15 |
---|---|
Male gender, n (%) | 12 (75) |
APACHE II on ICU admission, mean±SD | 21 ± 5 |
Characteristics of the malignancy, n (%) | |
Hematologic malignancy | 10 (62.5) |
Solid tumor | 6 (37.5) |
Status of the malignancy at the day of SLB | |
Recent diagnosis in 3 months | 3 (19) |
Stable disease | 5 (31) |
Progression disease | 8 (50) |
Chemotherapy in one month, n (%) | 8 (50) |
HRCT before SLB, n (%) | 10 (62.5) |
BAL before SLB, n (%) | 15 (93.8) |
PaO2/FiO2 ratio (mmHg), mean±SD | 143 ± 55 |
PEEP (cm H2O), mean±SD | 10.9 ± 2.2 |
Tidal volume (ml/kg PBW) | 7.3 ± 1.2 |
ALI score, mean±SD | 3.1 ± 0.3 |
Days from ARDS onset to SLB, mean±SD | 3.0 ± 1.5 |
Mechanical ventilator days | 10.1 ± 6.6 |
ICU length of stay | 11.3 ± 6.3 |
Hospital length of stay | 31.6 ± 18.6 |